Histogen Inc. Common Stock
HSTO
HSTO was delisted on the 4th of October, 2023.
42 hedge funds and large institutions have $9.15M invested in Histogen Inc. Common Stock in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 13 closing their positions.
402% more call options, than puts
Call options by funds: $1.71M | Put options by funds: $340K
60% more repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 10
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
19% less funds holding
Funds holding: 52 → 42 (-10)
36% less capital invested
Capital invested by funds: $14.4M → $9.15M (-$5.21M)
77% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.12M |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
+$457K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$185K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$161K |
| 5 |
Wells Fargo
San Francisco,
California
|
+$106K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SI
Sofinnova Investments
Menlo Park,
California
|
-$1.29M |
| 2 |
Two Sigma Investments
New York
|
-$433K |
| 3 |
Group One Trading
Chicago,
Illinois
|
-$317K |
| 4 |
BFM
Boothbay Fund Management
New York
|
-$287K |
| 5 |
CCM
Courage Capital Management
Nashville,
Tennessee
|
-$130K |
HSTO Hedge Fund Activity: Q1 2019 in Review
42 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Histogen Inc. Common Stock (HSTO) for Q1 2019, worth a combined $9.15M — down 36% from $14.4M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of HSTO and 3 opened new positions — a net loss of 10 holders — while 10 trimmed existing stakes and 16 added.
The largest buyer was Vanguard Group, adding an estimated $2.12M. The largest seller was Sofinnova Investments, exiting entirely with an estimated $1.29M sold.
- 42 institutional investors held Histogen Inc. Common Stock (HSTO) as of Q1 2019, down from 52 in Q4 2018.
- Funds reported $9.15M of Histogen Inc. Common Stock stock for Q1 2019, down 36% quarter-over-quarter.
- 3 funds opened new Histogen Inc. Common Stock positions in Q1 2019 and 13 closed out, a net change of -10 holders.
- The largest Histogen Inc. Common Stock buyer in Q1 2019 was Vanguard Group, an estimated $2.12M added.
- The largest Histogen Inc. Common Stock seller in Q1 2019 was Sofinnova Investments, an estimated $1.29M sold.
Based on aggregated 13F filings for Q1 2019.